Sl no

Title of the project

Year

Name of investigators

Funding agency if any

Duration of project

1

Role of Systematic lymphadenectomy in Epithelial Ovarian Cancer

2014

Dr. Kiran Kulkarni

Dr. Elizabeth Vallikad

Dr. Premalatha

Dr. Sumangala G

Dr. Geeta Acharya

Dr. Vishakha

nil

1 year

2

Occurrence of high risk Human Papilloma virus genotypes (16, 18) associated with invasive cervical carcinoma from a tertiary care centre- A pilot study

2016

Dr. Premalatha

(Co- Guide)

nil

2 years

3

Quality of life assessment in women with gynecological cancers in the Indian scenario

2015

Dr. Geeta Acharya

Dr. Elizabeth Vallikad

Dr. Vidya Sathyanarayanan

nil

2 years

4

Development and validation of a Novel device for screening of cervical intraepithelial neoplasia in a low resource setting

2016

Dr. Kiran Kulkarni

Dr. Premaltha

Dr. Geeta Acharya

Dr. Sumangala G

Dr. Vishakha B

Dr. Rashmi TN

Dr. Elizabeth Vallikad

nil

1 year

5

A study of adverse Dr.ug reaction profile, quality of life and pharmacotherapy in patients undergoing chemotherapy and chemoradiation in the gynaecologic –oncology department of a tertiary care hospital

2019

Dr. Vishakha B

Dr. Geeta Acharya

Dr. Richa

Dr. Mangala

nil

1 year

6

Understanding the Mechanisms of chemoresistance in ovarian cancer in Indian women

2019

Dr. Premalatha. T.S

Dr. Sabarnathan Radhakrishnan

Dr. Sudhir Krishna

Dr. Julian Crasta

Dr. Swetha Raghavan

Core grant from National centre for biological sciences

1 year

7

Observance of the enhanced recovery after surgery practices in gynaecologic Oncology and its impact on surgical and patient reported health outcomes

2018

Dr. Pinnaka Vamsi

Dr. Elizabeth Vallikad

Dr. Premalatha TS

nil

2 years

8

Smart ColpoSpec -Development of a lesion recognition algorithm for detection of cervical intraepithelial lesion using colposcopic images of the cervix

2020

Dr. Geeta Acharya

Prof Premalatha TS

Dr. Kiran Kulkarni

Dr. Vishakha B

Sponsored (BIRAC funding)

1 year

9

The prognostic role of combination of CA-125 and chemotherapy response score in advanced high grade epithelial ovarian serous carcinoma

2020

Dr. Ramya DR.

Dr. Premalatha

Dr. Kiran Kulkarni

Dr. Geeta Acharya

Dr. Vishakha B

10

Khorana score as a predictive tool of venous thromboembolism in gynaecologic cancer patients

2020

Dr. Mohana Priya

Dr. Kiran Kulkarni

Dr. Geeta Acharya

Dr. Premalatha

nil

1 year

11

Clinical Outcomes in High Risk Endometrial Cancer: A single institution retrospective Study

2020

Dr. Pinnaka Vamsi

Dr. Premalatha

Dr. Kiran Kulkarni

Dr. Geeta Acharya

Dr. Vishakha B

Dr. Mohana Priya

Dr. Ramya DR.

nil

1 year

12

An audit of carcinoma cervix with comparison of FIGO 2015 and FIGO 2018 classification systems -A 5 year single institutional study

2021

Dr. Sharanya S

Dr. Kiran Kulkarni

Dr. Geeta Acharya

Dr. Gayatri Ravikumar

nil

1 year

14

Evaluation of serum Magnesium and Creatinine levels in patients with cervical carcinoma receiving concurrent chemoradiotherapy with cisplatin with magnesium supplementation in a tertiary care hospital

20-21

Dr. Nayana. S M

Dr. Anitha Bijoor

Dr. Premalatha

Nil

3 years

15

Comparison of PAP smear and Visual inspection with acetic acid under mobile magnification (VIAM) in the detection of premalignant lesions of cervix: A validation study

20-21

Dr. Annie Dettin

Dr. Manjula

Dr. Premalatha. T. S.

Nil

3 years

16

Endometroid endometrial adenocarcinoma: Association of morphological pattern of invasion with clinopathological prognostic factors and markers of invasion

Dr. Rosmy John

Dr. Julian Crasta

Dr. Premalatha. T. S.

Nil

3 years

17

Expression patterns of p53 and p16 immunohistochemistry in vulvar squamous neoplasias and its correlation with morphological subtyping of HPV independent and HPV associated lesions.

Dr. Gayathri

Dr. Julian Crasta

Dr. Rajalaxmi

Dr. Premalatha. T. S.

Research Society

2 years